Cigna Healthcare (Commercial) · epidural steroid injection
✓ conditional · commercial
Criteria checklist
0 of 6 ticked- enumerated: yes
- covered:
- name: Radiculitis / radicular pain / radiculopathy
- criteria:
- imaging: concordant; advanced imaging within 24 months required for cervical/thoracic
- imaging guided: fluoroscopy or CT with contrast
- name: Spinal stenosis
- criteria:
- imaging: MRI/CT +/- myelography within 24 months
- name: Diagnostic selective nerve root block (SNRB)
- criteria:
- anesthetic only: yes
- single level: yes
- investigational:
- ultrasound-guided ESI / SNRB
- any ESI without fluoroscopic/CT guidance + contrast (except emergent/pregnancy)
- required: yes
- min duration months: not stated in the policy
- min duration weeks: 4
- also requires: participation in a comprehensive pain program (PT, education, psychosocial support, oral meds)
- satisfied by:
- failed >=4 weeks + pain-program participation
- contraindicated
- modalities named:
- physical therapy
- patient education
- psychosocial support
- oral medications
- required: no
- min duration days: not stated in the policy
- success criteria: not stated in the policy
- threshold is binding: no
- required: no
- must clear: no
- note posture: not required (but a comprehensive pain program incl. psychosocial support is required)
- required: yes
- modalities:
- fluoroscopy
- CT
- contrast: required
- excluded:
- ultrasound
- applies: yes
- sessions per 6mo per region per episode: 3
- sessions per region per 12mo: 4
- repeat requires: >=50% relief for >=2 weeks
- series of three: not supported
- tfesi levels per session: 2
Cigna delegates ESI to eviCore CMM-200 — radicular pain or stenosis with concordant imaging (advanced imaging within 24 months for cervical/thoracic), fluoro/CT with contrast. DISTINCTIVE: requires participation in a COMPREHENSIVE PAIN PROGRAM (PT + education + psychosocial + oral meds) in addition to >=4 weeks conservative care. Caps: <=3 sessions/6mo/region/episode and <=4/rolling- 12mo/region; "series of three" not supported; repeat needs >=50% relief for >=2 weeks. From the actual fetched eviCore PDF. PENDING: 2026-08-04 successor.
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Lean narrative A&P attestation. `***` = fill-in. Fully self-contained — rendered from eviCore CMM-200, Cigna-delegated. DISTINCTIVE: comprehensive pain-program participation is required on top of the 4-week conservative floor; "series of three" is not supported.
.ESICIGNA Assessment: *** — radiculitis / radicular pain / radiculopathy in a *** (C/T/L-S) distribution, or spinal stenosis, with concordant imaging at *** (advanced imaging within 24 months is required for cervical and thoracic levels; for stenosis, MRI/CT with or without myelography within 24 months). Medical necessity per Cigna eviCore CMM-200: conservative care has failed or was contraindicated over >=4 weeks, and the patient has participated in a comprehensive pain program — physical therapy, patient education, psychosocial support, and oral medications: *** . The injection will be placed under fluoroscopy or CT with contrast; ultrasound is not covered, and an ESI without fluoroscopic/CT guidance and contrast is not covered except in emergent circumstances or pregnancy. Plan: *** epidural steroid injection — transforaminal (64483/64484 lumbar-sacral; 64479/64480 cervical-thoracic) or interlaminar (62323 lumbar-sacral; 62321 cervical-thoracic) — at level ***, under fluoroscopic/CT guidance with contrast, with TFESI limited to <=2 levels per session, <=3 sessions per region per 6 months per episode, and <=4 sessions per region per rolling 12 months. [If repeat:] the prior ESI gave >=50% relief for >=2 weeks. Risks, benefits, and alternatives discussed; consent obtained.
Where this payor diverges from the Medicare baseline
Cautions
Prior-auth pathway
- required: yes
- pathway: eviCore / Evernorth
Provenance
- authority:
- type: commercial_policy
- id: Cigna eviCore CMM-200
- title: Epidural Steroid Injections (CMM-200)
- delegated by: Cigna (authored by eviCore / Evernorth)
- applies because: Cigna delegates ESI UM to eviCore CMM-200
- source: https://www.evicore.com/sites/default/files/clinical-guidelines/2026-02/Cigna_Epidural%20Steroid%20Inj%20(CMM-200)_V1.1.2025_Eff02.25.2026_pub01.30.2026_upd02.13.2026.pdf
- archived copy:
sources/evicore_cmm200-esi_2026-02-25.pdf(sha256 0b5bf17ce112… — kept in the content repo, not served here) - effective: 2026-02-25 · payor last reviewed: 2026-02-25 · we verified: 2026-07-24 · v1
Change history
- 2026-07-24commercial cells: re-verify 27 source PDFs by SHA-256 (Carelon/eviCore/UHC/Cigna) - all unchanged vs committed archive; last_verified -> 2026-07-24
3615c231f0 - 2026-06-30Archive commercial source PDFs into sources/ + wire source_file/source_hash
c5466694c8 - 2026-06-28Add commercial ESI cells: Anthem(Carelon), UHC, Cigna(eviCore)
ecc9a1b23e